Use of the clinical laboratory in the diagnosis and treatment of depression

William F. Hoffman, Beal Essink, Thomas Hansen

    Research output: Contribution to journalArticle

    Abstract

    This article reviews the importance of laboratory testing in the diagnosis of depressive disorders and for management during treatment. There is no useful test to establish the presence of a Major Depressive Episode, but medical conditions requiring laboratory testing should be excluded before arriving at a diagnosis. Treatment may lead to physiologic dysfunction warranting monitoring various laboratory functions. The following tests should be considered in establishing diagnosis and to establish baseline levels for comparison in subsequent monitoring: ■ Electrolytes ■ TSH (and free T4 if TSH is abnormal) ■ CBC with platelet count ■ Creatinine and BUN ■ LFTs (AST, alkaline phosphatase) ■ Calcium and phosphate ■ Pregnancy testing (hCG) for selected female patients. Lithium, carbamazepine, and valproic acid levels should be monitored when these medications are used to treat patients with depression.

    Original languageEnglish (US)
    Pages (from-to)511-514
    Number of pages4
    JournalLaboratory Medicine
    Volume33
    Issue number7
    StatePublished - 2002

    Fingerprint

    Clinical laboratories
    Clinical Laboratory Techniques
    Depression
    Testing
    Monitoring
    Blood Urea Nitrogen
    Carbamazepine
    Valproic Acid
    Depressive Disorder
    Platelets
    Platelet Count
    Lithium
    Electrolytes
    Alkaline Phosphatase
    Creatinine
    Therapeutics
    Pregnancy

    ASJC Scopus subject areas

    • Clinical Biochemistry
    • Pathology and Forensic Medicine

    Cite this

    Use of the clinical laboratory in the diagnosis and treatment of depression. / Hoffman, William F.; Essink, Beal; Hansen, Thomas.

    In: Laboratory Medicine, Vol. 33, No. 7, 2002, p. 511-514.

    Research output: Contribution to journalArticle

    Hoffman, William F. ; Essink, Beal ; Hansen, Thomas. / Use of the clinical laboratory in the diagnosis and treatment of depression. In: Laboratory Medicine. 2002 ; Vol. 33, No. 7. pp. 511-514.
    @article{154c836b6e8c48069cb4859e3979f98d,
    title = "Use of the clinical laboratory in the diagnosis and treatment of depression",
    abstract = "This article reviews the importance of laboratory testing in the diagnosis of depressive disorders and for management during treatment. There is no useful test to establish the presence of a Major Depressive Episode, but medical conditions requiring laboratory testing should be excluded before arriving at a diagnosis. Treatment may lead to physiologic dysfunction warranting monitoring various laboratory functions. The following tests should be considered in establishing diagnosis and to establish baseline levels for comparison in subsequent monitoring: ■ Electrolytes ■ TSH (and free T4 if TSH is abnormal) ■ CBC with platelet count ■ Creatinine and BUN ■ LFTs (AST, alkaline phosphatase) ■ Calcium and phosphate ■ Pregnancy testing (hCG) for selected female patients. Lithium, carbamazepine, and valproic acid levels should be monitored when these medications are used to treat patients with depression.",
    author = "Hoffman, {William F.} and Beal Essink and Thomas Hansen",
    year = "2002",
    language = "English (US)",
    volume = "33",
    pages = "511--514",
    journal = "Laboratory Medicine",
    issn = "0007-5027",
    publisher = "American Society of Clinical Pathologists",
    number = "7",

    }

    TY - JOUR

    T1 - Use of the clinical laboratory in the diagnosis and treatment of depression

    AU - Hoffman, William F.

    AU - Essink, Beal

    AU - Hansen, Thomas

    PY - 2002

    Y1 - 2002

    N2 - This article reviews the importance of laboratory testing in the diagnosis of depressive disorders and for management during treatment. There is no useful test to establish the presence of a Major Depressive Episode, but medical conditions requiring laboratory testing should be excluded before arriving at a diagnosis. Treatment may lead to physiologic dysfunction warranting monitoring various laboratory functions. The following tests should be considered in establishing diagnosis and to establish baseline levels for comparison in subsequent monitoring: ■ Electrolytes ■ TSH (and free T4 if TSH is abnormal) ■ CBC with platelet count ■ Creatinine and BUN ■ LFTs (AST, alkaline phosphatase) ■ Calcium and phosphate ■ Pregnancy testing (hCG) for selected female patients. Lithium, carbamazepine, and valproic acid levels should be monitored when these medications are used to treat patients with depression.

    AB - This article reviews the importance of laboratory testing in the diagnosis of depressive disorders and for management during treatment. There is no useful test to establish the presence of a Major Depressive Episode, but medical conditions requiring laboratory testing should be excluded before arriving at a diagnosis. Treatment may lead to physiologic dysfunction warranting monitoring various laboratory functions. The following tests should be considered in establishing diagnosis and to establish baseline levels for comparison in subsequent monitoring: ■ Electrolytes ■ TSH (and free T4 if TSH is abnormal) ■ CBC with platelet count ■ Creatinine and BUN ■ LFTs (AST, alkaline phosphatase) ■ Calcium and phosphate ■ Pregnancy testing (hCG) for selected female patients. Lithium, carbamazepine, and valproic acid levels should be monitored when these medications are used to treat patients with depression.

    UR - http://www.scopus.com/inward/record.url?scp=0036291133&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0036291133&partnerID=8YFLogxK

    M3 - Article

    AN - SCOPUS:0036291133

    VL - 33

    SP - 511

    EP - 514

    JO - Laboratory Medicine

    JF - Laboratory Medicine

    SN - 0007-5027

    IS - 7

    ER -